The brain is one of the highest consumers of glutathione, and its deficiency is directly implicated in the progression of neurodegenerative conditions
59% Increased sleep Within 130 minutes of administration 97% Relief of symptoms Opioid withdrawal (107 patients) 86% Pain reduction Patients with chronic pain (6/7) Dog of DL50 Security Profile No lethal dose ever determined 9 amino acids Nonapeptide WAGGDASGE Sequence How does the DSIP work
GHK-Cu products sold for research are not intended to diagnose, treat, cure, or prevent disease
Compared to healthy age-matched individuals whose samples were taken before the pandemic started in 2019, patients hospitalized with COVID-19 had significantly increased levels of oxidative stress and oxidant damage, and markedly reduced levels of glutathione
injectable administration bypasses gastrointestinal processing
Performed on every batch to confirm the active ingredient is present at the labeled concentration